Anticorps Recombinant de lapin anti-CXCL8/IL-8
CXCL8/IL-8 Recombinant Antibody for FC (Intra)
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
FC (Intra)
Conjugaison
Non conjugué
CloneNo.
240889B2
N° de cat : 98137-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
98137-1-PBS cible CXCL8/IL-8 dans les applications de FC (Intra) et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Lapin / IgG |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | Protéine recombinante |
Nom complet | interleukin 8 |
Masse moléculaire calculée | 99 aa, 11 kDa |
Numéro d’acquisition GenBank | BC013615 |
Symbole du gène | IL-8 |
Identification du gène (NCBI) | 3576 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Protein A purfication |
Tampon de stockage | PBS only |
Conditions de stockage | Store at -80°C. |
Informations générales
Interleukin 8 (IL-8), also known as CXCL8, is a CXC chemokine family member. This chemokine is secreted by a variety of cell types including monocyte/macrophages, T cells, neutrophils, fibroblasts, endothelial cells, and various tumor cell lines in response to inflammatory stimuli. IL-8 has two primary functions. It induces chemotaxis in target cells, primarily neutrophils but also other granulocytes, causing them to migrate toward the site of infection. IL-8 also induces phagocytosis once they have arrived. This gene is believed to play a role in the pathogenesis of bronchiolitis, a common respiratory tract disease caused by viral infection. IL-8 is also known to be a potent promoter of angiogenesis. IL-8 has been associated with tumor angiogenesis, metastasis, and poor prognosis in breast cancer. IL-8 may present a novel therapeutic target for estrogen driven breast carcinogenesis and tumor progression.